IN8bio Inc.
INAB | NASDAQ
$1.09
+$0.01 (+0.93%)
At close: Sep 21, 2026, 3:59 PM ET
$1.05
-$0.04 (-3.58%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.5M | n/a | 2.5M | n/a | n/a | n/a |
Gross Profit | -2.5M | n/a | -2.5M | n/a | n/a | n/a |
Operating Income | -19.86M | -30.44M | -30.34M | -28.52M | -14.65M | -8.56M |
Interest Income | 421K | 230K | n/a | n/a | n/a | n/a |
Pretax Income | -19.44M | -30.44M | -30.01M | -28.52M | -14.65M | -8.56M |
Net Income | -19.44M | -30.44M | -30.01M | -28.52M | -14.65M | -8.56M |
Selling & General & Admin | 9.65M | 12.64M | 13.51M | 14.46M | 7.31M | 3.18M |
Research & Development | 10.21M | 16.96M | 16.83M | 14.06M | 7.35M | 5.38M |
Other Expenses | -2.5M | 838K | -2.5M | n/a | n/a | n/a |
Operating Expenses | 17.36M | 30.44M | 27.84M | 28.52M | 14.65M | 8.56M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 19.86M | 30.44M | 30.34M | 28.52M | 14.65M | 8.56M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 4.37M | 1.78M | 995.5K | 698.93K | 626.04K | 645.15K |
Shares Outstanding (Diluted) | 4.37M | 1.78M | 995.5K | 698.93K | 626.04K | 645.15K |
EPS (Basic) | -4.44 | -0.57 | -1 | -1.36 | -0.78 | -0.53 |
EPS (Diluted) | -4.44 | -0.57 | -1 | -1.36 | -0.78 | -0.53 |
EBITDA | -16.94M | -26.94M | -27.51M | -27.42M | -13.87M | -8.47M |
EBIT | -19.44M | -29.6M | -30.01M | -28.52M | -14.65M | -8.56M |
Depreciation & Amortization | 2.5M | 2.66M | 2.5M | 1.1M | 788K | 88K |
Add to Watchlist
Select watchlists to add or remove INAB